Literature DB >> 23241049

Decreased acid suppression therapy overuse after education and medication reconciliation.

R Gupta1, J Marshall, J C Munoz, R Kottoor, M M Jamal, K J Vega.   

Abstract

BACKGROUND: Acid suppression therapy (AST) is commonly overprescribed in hospitalised patients. This indiscriminate use increases cost and drug-related side effects. Minimal data is available on interventions aimed at reducing the burden of overprescription. The aim of our study was to evaluate the impact of education and medication reconciliation forms use on admission as well as discharge, on AST overuse in hospitalised patients.
METHODS: A retrospective chart review of randomly selected patients admitted to the general medicine service at University of Florida Health Science Center/Jacksonville was performed prior to and after the introduction of interventions (education/medication reconciliation) aimed at reducing AST overuse. The percentage of patients started on inappropriate AST, the admitting diagnosis, indications for starting AST and discharge on these medications was compared in the pre and postintervention groups.
RESULTS: Acid suppression therapy use declined from 70% (279/400) in the preintervention period to 37% (100/270) postintervention (p < 0.001). There was a reduction in inappropriate prescriptions from 51% (204/400) pre to 22% (60/270) postintervention (p < 0.02). Stress ulcer prophylaxis in low-risk patients or the concomitant use of ulcerogenic drugs continued to motivate inappropriate AST therapy in most patients. Postintervention, only 20% (12/60) of patients were discharged on unneeded AST compared with 69% (140/204) in the preintervention group (p < 0.001).
CONCLUSION: Interventions consisting of education and use of medication reconciliation forms decreased inappropriate prescription of AST on admission and discharge. This can significantly decrease cost to the healthcare system and the risk of drug interactions.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23241049     DOI: 10.1111/ijcp.12046

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  5 in total

1.  Measures Used to Assess the Impact of Interventions to Reduce Low-Value Care: a Systematic Review.

Authors:  Jennifer K Maratt; Eve A Kerr; Mandi L Klamerus; Shannon E Lohman; Whit Froehlich; R Sacha Bhatia; Sameer D Saini
Journal:  J Gen Intern Med       Date:  2019-06-27       Impact factor: 5.128

2.  Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.

Authors:  Rebekah A Wahking; Randal L Steele; Rachel E Hanners; Sean M Lockwood; Kelly W Davis
Journal:  Hosp Pharm       Date:  2017-12-13

3.  Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.

Authors:  Devada Singh-Franco; David R Mastropietro; Miriam Metzner; Michael D Dressler; Amneh Fares; Melinda Johnson; Daisy De La Rosa; William R Wolowich
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

4.  Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit.

Authors:  Niloofar Rafinazari; Saeed Abbasi; Shadi Farsaei; Marjan Mansourian; Peyman Adibi
Journal:  J Res Pharm Pract       Date:  2016 Jul-Sep

5.  Peer-pressure and overuse: The effect of a multimodal approach on variation in benzodiazepine prescriptions in a network of public hospitals.

Authors:  Rosaria Del Giorno; Andrea Ottini; Angela Greco; Kevyn Stefanelli; Florenc Kola; Luca Clivio; Alessandro Ceschi; Luca Gabutti
Journal:  Int J Clin Pract       Date:  2019-12-09       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.